Evidence map›Paper›PMID 31037466›Full record

ReviewCurrent psychiatry reports2019

The Relationship Between Epilepsy and Anxiety Disorders.

Coraline Hingray, Aileen McGonigal, Iliana Kotwas, Jean-Arthur Micoulaud-Franchi

3 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Current psychiatry reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05032105 phase1active not recruitingnot on this mapstarted 2024, after this paper: background citation

.An Open-label Clinical Trial Evaluating the ExAblate Model 4000 Type-1 Focused Ultrasound Unilateral Thalamotomy for Patients With Treatment-refractory Focal Onset Epilepsy and Comorbid Anxiety.

TypeinterventionalSponsorOhio State UniversityRan2024 to 2027Enrolled2ConditionsAnxiety, Medication-refractory Focal-onset EpilepsyArmsMagnetic Resonance Imaging-guided Focused Ultrasound Ablation (MRgFUSA)
NCT05296057 nacompletednot on this mapstarted 2023, after this paper: background citation

Pilot Study to Evaluate Virtual Reality Exposure Therapy on People With Epilepsy and Related Anxiety

TypeinterventionalSponsorUniversity Health Network, TorontoRan2023 to 2023Enrolled5ConditionsEpilepsy, Anxiety Disorders and SymptomsArmsParticipants Receiving VR-Exposure Therapy Treatment
NCT06028945 nacompletednot on this mapstarted 2024, after this paper: background citation

Randomized Controlled Trial Evaluating the Impact of Virtual Reality Exposure Therapy on Epilepsy/Seizure-Specific Interictal Anxiety In People With Epilepsy

TypeinterventionalSponsorUniversity Health Network, TorontoRan2024 to 2024Enrolled14ConditionsEpilepsy, Anxiety DisordersArmsHMD: Virtual Reality Exposure Therapy, HMD: Neutral Game
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Observational
  11. Article
  12. Burden of psychiatric disease inversely correlates with Alzheimer's age at onset.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  13. Article
  14. Article
  15. Aberrant functional connectivity of amygdala subregions in temporal lobe epilepsy with ictal panic.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  16. Ethanolic and aqueous extracts ofIBRO neuroscience reports · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Coraline HingrayPôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy Centre Psychothérapique de Nancy, 54521, Laxou, France.
Aileen McGonigalInserm, INS, Institut de Neurosciences des Systèmes, Aix Marseille Univ, Marseille, France.
Iliana KotwasLaboratoire Parole et Langage UMR 7309, Aix-Marseille Université, Marseille, France.
Jean-Arthur Micoulaud-FranchiService d'explorations fonctionnelles du système nerveux, Clinique du sommeil, CHU de Bordeaux, Place Amélie Raba-Léon, 33076, Bordeaux, France. jarthur.micoulaud@gmail.com.
Aix-Marseille Université · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Universitaire de Bordeaux · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThe current review aims at providing an overview of relevant aspects of anxiety symptoms and anxiety disorders (AD) in adults patients with epilepsy (PWE). RECENT

findingsFirstly, the appropriate diagnosis of type of anxiety symptoms and AD in PWE will be presented. Anxiety symptoms are often peri-ictal and classified in relation to their temporal occurrence to seizures. Anxiety symptoms are of three types: preictal (preceding a seizure), ictal (presenting as part of the seizure symptoms and signs), and postictal (occurring within 72 h of a seizure). AD are diagnosed in the interictal period and occur independently of seizures. Four specific AD in PWE can be objectified: anticipatory anxiety of epileptic seizures (AAS), seizure phobia, epileptic social phobia, and epileptic panic disorder. Secondly, the bidirectional pathophysiological relationship between anxiety and epilepsy will be described. Anxiety is a trigger for seizures in some patients, and the notion of stress and arousal is essential to understand the relationship between anxiety and seizure. Moreover, seizures arising from the limbic network especially involving amygdala, which may express fear-related semiology, provide insight into the pathophysiology of AD comorbidities. Thirdly, the methods of screening for AD and anxiety symptoms will be detailed. Fourthly, the pharmacological and psychobehavioral management of anxiety symptoms and AD in PWE will be presented. Arousal-based approaches for preictal and ictal symptoms and anxiety-based approaches for postictal and interictal symptoms will be presented. Despite lack of evidence-based approaches, it is recognized that management of epilepsy is not only about controlling seizures, but also depends heavily on detecting, correctly diagnosing, and appropriately managing anxiety symptoms and AD comorbidities, in order to maximize quality of life. Improving self-control and self-efficacy is of fundamental importance in the management of PWE. Further rigorously designed studies focusing on anxiety symptoms and AD are essential to improve the overall care of PWE.

Indexed as

AnxietyAnxiety DisordersComorbidityEpilepsyHumansQuality of LifeSeizuresAnxietyEpilepsyPerceived self-controlPsychiatric comorbidityPsychiatric symptomsQuality of lifeSeizure control

Identifiers

PMID31037466
OpenAlexW2943787971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.